Follow the Thyrocare Tech stock price and the full management transaction log of the company, a listed equity based in India. Shares trade on IN IN, under the oversight of SEBI (PIT + SAST). Operating in the Technology sector, Thyrocare Tech has recorded 7 public disclosures. Market capitalisation: €88.3bn. The latest transaction was reported on 1 July 2026 (Acquisition). Among the most active insiders: Nikhil Bodhankar. The full history is accessible without an account.
7
Insider Decl.
0
Thresholds
€3,443
2 ops.
Buy Volume
€8,006
5 ops.
Sell Volume
45Σ signal
Buys €3,443€8,006 Sells
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 7,362 of 26,212 companies
62.4
score / 100
Value
36
Quality
89
FCF yld2.3%
Earn yld2.0%
EV/EBITDA30.1x
ROE29%
Gross mgn73%
Net mgn20%
Debt/EBITDA0.2x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
450 shares@ ₹546.50100.0% of flowEquity SharesMarket PurchaseSEBI:0bc61903aea47be541ecd5b3d45888e8252e5dff
Ideal exit: 9 Mar 2027 (T+270)
7 of 7 declarations
About Thyrocare Tech
Thyrocare Tech is a company specializing in diagnostic and laboratory testing services. It primarily operates in the Indian market and is listed on the Bombay Stock Exchange.